论文部分内容阅读
介入法已成为治疗肝癌的非外科主要治疗手段。其中血管性介入治疗由初期单纯肝动脉灌注化疗 (ＴＡＩ)逐步改进为灌注化疗加栓塞 (ＴＡＣＥ) ,使疗效有了显著的提高。目前 ,ＴＡＣＥ是不宜手术切除肝癌的首选疗法 ,广泛应用于临床。超液化碘油 (ｌｉｐｉｏｄｏｌ)是现今最常用和
Intervention method has become the main non-surgical treatment of liver cancer treatment. Among them, vascular interventional therapy is gradually improved from initial simple hepatic arterial infusion chemotherapy (TAI) to perfusion chemotherapy plus embolization (TACE), which has markedly improved the curative effect. At present, TACE is not the first choice of surgical resection of liver cancer, widely used in clinical. Lipiodol is the most commonly used today